Log In
Print
BCIQ
Print
Print this Print this
 

Betaferon, Betaseron, Interferon beta-1b

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInterferon (IFN) beta-1b
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat early multiple sclerosis (MS); Treat multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS); Treat secondary progressive multiple sclerosis (SPMS); Treat secondary progressive multiple sclerosis (SPMS) or relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation

Partner

Bayer AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today